Aquinox Pharmaceuticals CEO David Main's 2018 pay jumps 39% to $4.2M
Aquinox Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: October 2, 2019
Aquinox Pharmaceuticals reported fiscal year 2018 executive compensation information on October 2, 2019.
In 2018, three executives at Aquinox Pharmaceuticals received on average a compensation package of $2.6M, a 33% increase compared to previous year.
Average pay of disclosed executives at Aquinox Pharmaceuticals
David J. Main, Chief Executive Officer, received $4.2M in total, which increased by 39% compared to 2017. 81% of Main's compensation, or $3.4M, was in option awards. Main also received $268K in non-equity incentive plan, $535K in salary, as well as $10K in other compensation.
Lloyd Mackenzie, Chief Operating Officer, received a compensation package of $1.9M. 59% of the compensation package, or $1.2M, was in option awards.
Kamran Alam, Chief Financial Officer, earned $1.8M in 2018, a 23% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on October 2, 2019.